<DOC>
	<DOCNO>NCT00029185</DOCNO>
	<brief_summary>This compassionate-use treatment study provide Dehydrex patient corneal erosion syndrome previously use Dehydrex .</brief_summary>
	<brief_title>Study Dehydrex Patients With Corneal Erosion</brief_title>
	<detailed_description>This study continue provide Dehydrex patient receive previously study . Patients continue treat current dose Dehydrex . Upward dose adjustment may make clinically indicated . Patients undergo eye exam every 3 4 month often . Downward dose titration attempt patient stable , free symptom , willing attempt downward adjustment . In patient able discontinue medication , duration healing determine . In patient experience recurrence discontinue medication , Dehydrex restart dose high minimum effective dose . After least 8 week treatment resolution symptom , dose may reduce . Further attempt discontinue medication make . Completion date provide represent completion date grant per OOPD record</detailed_description>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Corneal Diseases</mesh_term>
	<criteria>Inclusion criterion : Clinical diagnosis symptomatic recurrent corneal syndrome due anterior membrane dystrophy posttraumatic abrasion Not responsive standard medical therapy artificial tear , hypertonic saline , bandage soft contact lenses At least 3 episode erosion within past 4 month document slit lamp examination Exclusion criterion : Allergy component medication use Active ocular surface infection due bacteria , virus , fungus Chronic atopic disease affect ocular surface adnexa Dry eye , exposure , trichiasis , entropion , ectropion , neurotrophic keratopathy Concurrent use contact lenses Diagnosis persistent epithelial defect eye treat Concurrent use topical medication eye treat Any ocular eyelid surgery within past 6 month Preexisting corneal stromal edema Diabetes mellitus Postsurgical infection Dry eye condition 16 great Patient 's Dry Eye Questionnaire Other investigational medication within past 6 month Other corneal dystrophy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2001</verification_date>
	<keyword>Corneal Erosion</keyword>
	<keyword>Dextrans</keyword>
	<keyword>Administration , Topical</keyword>
	<keyword>Ophthalmic Solutions</keyword>
	<keyword>Thimerosal</keyword>
</DOC>